You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Johnson and Johnson
AstraZeneca
Moodys
McKesson
Express Scripts
Boehringer Ingelheim

Last Updated: February 27, 2021

DrugPatentWatch Database Preview

CLINICAL TRIALS PROFILE FOR FAMCICLOVIR

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

All Clinical Trials for Famciclovir

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00098046 Famciclovir Oral Pediatric Formulation in Children 1-12 Years of Age With Varicella Zoster Infection Completed Novartis Phase 3 2005-07-01 Varicella zoster virus causes chickenpox in children and shingles in adults. Chickenpox is usually a self-limiting illness characterized by fever and a rash. Serious complications can include secondary bacterial infections, pneumonia, and encephalitis. Anti-viral treatment is not a standard of care in immunocompetent children, but is recommended whenever a risk of complication exists. This study will evaluate the safety and blood levels of a new formulation of famciclovir in children 1-12 years of age.
NCT00098059 Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection Completed Novartis Pharmaceuticals Phase 3 2005-02-01 This study will evaluate the safety and blood levels of a new pediatric formulation of Famvir in children 1-12 years of age. In Part A, patients will receive a single dose of famciclovir (12.5 mg/kg) to assess pharmacokinetics (PK) and safety. In Part B, patients will receive multiple doses of famciclovir alone or with concomitant oral anti-herpes therapy to assess safety and tolerability. Part B will start only after PK data from Part A had been analyzed.
NCT00129818 A Study to Evaluate the Effect of Famciclovir in Reducing Herpes Virus Shedding Completed Novartis Phase 4 2004-07-01 The study is designed to assess the efficacy and safety of famciclovir 250 mg twice a day (bid) suppressive treatment in men and women with herpes virus type 2 (HSV-2) infection, with and without a reported history of genital herpes and with or without herpes virus type 1 (HSV-1) seropositivity.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for Famciclovir

Condition Name

Condition Name for Famciclovir
Intervention Trials
Genital Herpes 4
Herpes Zoster 2
Herpes Simplex 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for Famciclovir
Intervention Trials
Herpes Genitalis 6
Herpes Labialis 3
Herpes Zoster 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for Famciclovir

Trials by Country

Trials by Country for Famciclovir
Location Trials
United States 78
Canada 7
Brazil 5
Panama 3
Australia 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for Famciclovir
Location Trials
Texas 6
Missouri 5
Ohio 4
North Carolina 4
Alabama 4
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for Famciclovir

Clinical Trial Phase

Clinical Trial Phase for Famciclovir
Clinical Trial Phase Trials
Phase 4 4
Phase 3 7
Phase 2/Phase 3 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for Famciclovir
Clinical Trial Phase Trials
Completed 16
Active, not recruiting 1
Recruiting 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for Famciclovir

Sponsor Name

Sponsor Name for Famciclovir
Sponsor Trials
Novartis 7
Novartis Pharmaceuticals 3
Roxane Laboratories 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for Famciclovir
Sponsor Trials
Industry 20
Other 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
McKesson
Mallinckrodt
Baxter
Harvard Business School
Johnson and Johnson

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.